retatrutide news today recency 3 Today, we shared new data from two Phase trials of retatrutide, our investigational triple agonist. Learn more: https://go.lilly.com/msrz1v Retatrutide (say that 3 times

1mg 2x/week (flat) 2 injections/week P/T Ratio: ~2.1 Use Case: Post-goal maintenance Create Your Custom Microdosing Protocol These pre-built schedules represent common approaches, but optimal dosing varies by individual

If its cloudy or contains particulates, do not use it

However, case series using DXA monitoring show that people who prioritize protein intake and resistance training can dramatically reduce or even eliminate lean mass loss while still losing substantial fat

For some patients: For others: The future role of Retatrutide will become clearer as longer-term data continues to emerge

From the time I signed up, I have been kept informed every step of the way